BioCentury
ARTICLE | Clinical News

Lifmior regulatory update

December 21, 2016 12:42 AM UTC

EMA’s CHMP recommended approval of Pfizer’s Lifmior etanercept, a product identical to Enbrel, to treat rheumatoid arthritis (RA), juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloart...

BCIQ Company Profiles

Pfizer Inc.